WESA1h
Penn expecting $467M windfall from COVID-19 vaccine royalty dispute
The university filed a lawsuit against BioNTech four months ago, claiming that the company licensed vaccine technology ...
Niagara Gazette2h
5 things we know and still don't know about COVID, 5 years after it appeared
Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn't ...
Pharmaceutical Technology9h
BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Pharmaceutical Technology9h
Trastuzumab pamirtecan by BioNTech for Solid Tumor: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
The Brighterside of News on MSN19h
Groundbreaking mRNA vaccine revolutionizes pancreatic cancer treatment
Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...